Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bacterial Toxins”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Early research (Phase 1)Study completedNCT02531685
What this trial is testing

Phase 1 Study of dmLT ID Vaccination in Healthy Adults

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableStudy completedNCT00314080
What this trial is testing

Treatment of Survivors After Botulism Outbreak

Who this might be right for
Respiratory FailureBotulism
Department of Medical Services Ministry of Public Health of Thailand 18
Not applicableStudy completedNCT02055183
What this trial is testing

BT-010 Registry for the Evaluation of Safety and Clinical Outcomes in Patients Treated With Botulinum Antitoxin

Who this might be right for
Botulism
Emergent BioSolutions 162
Early research (Phase 1)Study completedNCT04075175
What this trial is testing

Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects

Who this might be right for
Diphtheria
MassBiologics 41
Large-scale testing (Phase 3)Study completedNCT01491607
What this trial is testing

Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults

Who this might be right for
Anthrax
Emergent BioSolutions 200
Large-scale testing (Phase 3)Study completedNCT01226953
What this trial is testing

Immunogenicity and Safety of a Booster Dose of Monovalent Glycoprotein-Conjugated (Diptheria Toxin -CRM197) Hib Vaccine in 365-569 Days Old Healthy Infants

Who this might be right for
Haemophilus Influenzae Type b (Hib) Infection
Novartis Vaccines 660
Not applicableUnknownNCT05192148
What this trial is testing

Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile

Who this might be right for
Clostridium Difficile Infection
Fondation Hôpital Saint-Joseph 840
Early research (Phase 1)Study completedNCT02052934
What this trial is testing

Safety of Sublingual dmLT for ETEC

Who this might be right for
Gastroenteritis Escherichia Coli
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Not Yet RecruitingNCT02177721
What this trial is testing

Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario

Who this might be right for
Infections, Bacterial
Emergent BioSolutions 100
Not applicableStudy completedNCT02968758
What this trial is testing

Validation of the GenePOC CDiff Assay for the Detection of the Toxin B Gene From Toxigenic Clostridium Difficile Strains

Who this might be right for
Clostridium Difficile Infection
Meridian Bioscience, Inc. 2,461
Not applicableStudy completedNCT00279318
What this trial is testing

TEDDY - The Environmental Determinants of Diabetes in the Young

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 8,667
Post-approval studies (Phase 4)WithdrawnNCT06237465
What this trial is testing

Botulinum Toxin-A for Hidradenitis Suppurativa

Who this might be right for
Hidradenitis SuppurativaHidradenitis Suppurativa \(HS\)Hidradenitis Suppurativa, Acne Inversa
Yale University
Large-scale testing (Phase 3)Study completedNCT03182907
What this trial is testing

Bezlotoxumab (MK-6072) Versus Placebo in Children With Clostridium Difficile Infection (CDI) (MK-6072-001)

Who this might be right for
Clostridium Difficile Infection
Merck Sharp & Dohme LLC 148
Not applicableNot Yet RecruitingNCT03569514
What this trial is testing

Observational Study Evaluating Clinical Benefit and Safety of AIGIV (ANTHRASIL®) in Patients With Systemic Anthrax

Who this might be right for
Anthrax
Emergent BioSolutions 10
Not applicableStudy completedNCT00027183
What this trial is testing

Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionCystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 134
Testing effectiveness (Phase 2)Study completedNCT05090657
What this trial is testing

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

Who this might be right for
Surgical Site InfectionsNosocomial InfectionHealthcare Associated Infections
Ondine Biomedical Inc. 322
Testing effectiveness (Phase 2)Study completedNCT02296320
What this trial is testing

Study of the Efficacy and Safety of MEDI4893

Who this might be right for
Staphylococcus Aureus Pneumonia
MedImmune LLC 213
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Testing effectiveness (Phase 2)Study completedNCT02946190
What this trial is testing

The PertADO Geneva Trial

Who this might be right for
Pertussis
Siegrist Claire-Anne 60
Not applicableNot Yet RecruitingNCT07478471
What this trial is testing

Observational Study of Raxibacumab in Sporadic Cases of Systemic Anthrax

Who this might be right for
Infections, Bacterial
Emergent BioSolutions 10
Load More Results